Discontinuation report AVELOX I.V.
Report ID | 73405 |
Drug Identification Number | 02246414 |
Brand name | AVELOX I.V. |
Common or Proper name | Moxifloxacin Injection |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MOXIFLOXACIN |
Strength(s) | 400MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 250 mL |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-07-03 |
Actual discontinuation date | 2020-06-29 |
Remaining supply date | 2020-07-03 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2020-07-14 | French | Compare |
v14 | 2020-07-14 | English | Compare |
v13 | 2020-06-30 | French | Compare |
v12 | 2020-06-30 | English | Compare |
v11 | 2020-06-30 | English | Compare |
v10 | 2020-03-30 | French | Compare |
v9 | 2020-03-30 | English | Compare |
v8 | 2020-03-04 | French | Compare |
v7 | 2020-03-04 | English | Compare |
v6 | 2020-01-27 | French | Compare |
v5 | 2020-01-27 | English | Compare |
v4 | 2020-01-09 | French | Compare |
v3 | 2020-01-09 | English | Compare |
v2 | 2019-01-23 | French | Compare |
v1 | 2019-01-23 | English | Compare |
Showing 1 to 15 of 15